Your browser doesn't support javascript.
loading
RYK Gene Expression Associated with Drug Response Variation of Temozolomide and Clinical Outcomes in Glioma Patients.
Gonzalez, Ricardo D; Small, George W; Green, Adrian J; Akhtari, Farida S; Havener, Tammy M; Quintanilha, Julia C F; Cipriani, Amber B; Reif, David M; McLeod, Howard L; Motsinger-Reif, Alison A; Wiltshire, Tim.
Afiliación
  • Gonzalez RD; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Small GW; Center for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Green AJ; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Akhtari FS; Center for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Havener TM; Department of Biological Sciences, North Carolina State University, Raleigh, NC 27606, USA.
  • Quintanilha JCF; Bioinformatics Research Center, North Carolina State University, Raleigh, NC 27606, USA.
  • Cipriani AB; Biostatistics and Computational Biology Branch, Division of Intramural Research, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA.
  • Reif DM; Structural Genomics Consortium and Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • McLeod HL; Clinical Development, Foundation Medicine, Boston, MA 02115, USA.
  • Motsinger-Reif AA; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Wiltshire T; Predictive Toxicology Branch, Division of Translational Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, Durham, NC 27709, USA.
Pharmaceuticals (Basel) ; 16(5)2023 May 10.
Article en En | MEDLINE | ID: mdl-37242509
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pharmaceuticals (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pharmaceuticals (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos